Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

US Patent 10391097 · Granted Aug 27, 2019

Estimated economic value: $2,327,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted fused imidazole derivatives, pharmaceutical compositions, and method2024
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2024
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2024
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2024
Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-2024
Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-2024
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2023
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2023
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2023
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2023
Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-2022
Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-2022